Neonatal Clinical Trials 1

Moderator(s)

• 

  Brenda Poindexter, MD, MS (she/her/hers)

  Professor of Pediatrics; Chief, Division of Neonatology
  Pediatric and Newborn Medicine
  Emory University and Children's Healthcare of Atlanta
  Atlanta, Georgia, United States
• 

  Jonathan Davis, MD (he/him/his)

  Chief of Newborn Medicine
  Pediatrics
  Tufts University School of Medicine
  Boston, Massachusetts, United States

Presentations:

• 8:00 AM – 8:15 AM ET

  Ibuprofen versus Paracetamol for hemodynamically significant persistent ductus arteriosus: the IBUPAR trial
  

  Presenting Author: Marta Aguar-Carrascosa, PhD (she/her/hers) – La Fe University Hospital
• 8:15 AM – 8:30 AM ET

  Long-term Neurodevelopmental and Respiratory Outcomes after Selective Early Treatment of Patent Ductus Arteriosus: A Randomised Controlled Trial (Baby-OSCAR trial)
  

  Presenting Author: Samir Gupta, MD DM FRCPCH FRCPI (he/him/his) – Department of Engineering, Durham University, United Kingdom
• 8:30 AM – 8:45 AM ET

  Intratracheal budesonide mixed with surfactant to increase survival free of BPD in extremely preterm infants: Results of the international PLUSS trial
  

  Presenting Author: Brett J. Manley, MB BS (Hons.), PhD (he/him/his) – The Royal Women's Hospital, Melbourne, Australia
• 8:45 AM – 9:00 AM ET

  Moderately Preterm Infants Discharged with Caffeine at Home for Apnea: The MoCHA Trial
  

  Presenting Author: Waldemar A. Carlo, MD (he/him/his) – University of Alabama at Birmingham
• 9:00 AM – 9:15 AM ET

  Increased Alveolar Volume and Lung Diffusion Capacity in Former Preterm Infants Randomized to Two Extra Weeks of Continuous Positive Airway Pressure (CPAP) in the NICU
  

  Presenting Author: Cindy T. McEvoy, MD, MCR (she/her/hers) – Oregon Health & Science University
• 9:15 AM – 9:30 AM ET

  Intermittent Hypoxia and Caffeine in Infants Born Preterm: The ICAF Trial
  

  Presenting Author: Eric Eichenwald, MD (he/him/his) – Perelman School of Medicine at the University of Pennsylvania